therefore affords the possibility of capturing potential heterogeneity in the phenotype, and of modeling the association of SNPs with subgroup differences. A second aim was to obtain more detailed information concerning the specificity of the CHRNA5/A3/B4 gene cluster with respect to the risk of initiating a variety of different substances, in addition to detecting SNPs that differentiate between users and non-users.
